By Tim Bertram – Pharmaphorum –
The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions. However, while scientific breakthroughs in regenerative medicines like cell and gene therapies continue, the ability to transition these innovations from the research phase into commercially viable treatments remains a more significant challenge.
North Carolina’s regenerative medicine ecosystem has developed a strategic approach to addressing these challenges. Organisations and accelerators worldwide can learn from this model to enhance their own therapeutic development efforts, in the field of regenerative medicine or in other similar emerging areas of healthcare where the causes of product failure have been established.
